HomeInsightsStock Comparison

Cohance Lifesciences Ltd vs Shelter Pharma Ltd Stock Comparison

Cohance Lifesciences Ltd vs Shelter Pharma Ltd Stock Comparison

Last Updated on: May 27, 2025

Key Highlights

  • The Latest Trading Price of Suven Pharmaceuticals Ltd is ₹ 1092 as of 27 May 15:30.
  • The P/E Ratio of Suven Pharmaceuticals Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 yearsThe P/E Ratio of Shelter Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Suven Pharmaceuticals Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 yearsThe Market Cap of Shelter Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Suven Pharmaceuticals Ltd for the Dec '24 is ₹ 322.86 crore as compare to the Sep '24 revenue of ₹ 271.84 crore. This represent the growth of 18.77% The revenue of Shelter Pharma Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Suven Pharmaceuticals Ltd for the Dec '24 is ₹ 133.41 crore as compare to the Sep '24 ebitda of ₹ 118.13 crore. This represent the growth of 12.93% The ebitda of Shelter Pharma Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Suven Pharmaceuticals Ltd changed from ₹ 120.59 crore to ₹ 83.29 crore over 7 quarters. This represents a CAGR of -19.06% The net profit of Shelter Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Suven Pharmaceuticals Ltd changed from 23.57 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Shelter Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Suven Pharmaceuticals Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

About Shelter Pharma Ltd

  • Shelter Pharma Limited originally named as 'Shelter Pharmacy', was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat. The Company primarily focuses in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space.
  • The Company started with a few products about decades back.
  • However, over a period of time, it has added products to portfolio through in-house R & D efforts backed by sound knowledge of Ayurveda. The business was slowly expanded from local presence in Himmatnagar to well spread presence in the State of Gujarat.
  • The Company remained a family enterprise before incorporation of the Company with a consolidated position in Gujarat.

Suven Pharmaceuticals Ltd News Hub

News

Cohance Lifesciences' API Unit-IV clears USFDA inspection

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the Unite...

Read more

26 May 2025 08:46

News

Suven Pharmaceuticals allots 12.80 cr equity shares

Suven Pharmaceuticals has allotted 12,80,02,184 equity shares of the Company of face value...

Read more

09 May 2025 09:58

News

Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of Indi...

Read more

08 May 2025 09:39

News

Suven Pharmaceuticals receives regulatory nod for scheme of amalgamation

Suven Pharmaceuticals announced that it has received final approval from the Department of...

Read more

26 Apr 2025 12:56

News

Suven Pharmaceuticals to table results

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 M...

Read more

27 Mar 2025 09:42

News

Suven Pharmaceuticals receives credit ratings from CRISIL

Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings...

Read more

28 Feb 2025 19:46

Shelter Pharma Ltd News Hub

News

Shelter Pharma to table results

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025...

Read more

26 May 2025 15:35

News

Shelter Pharma receives order from Taha Drugs & Chemicals Co., Sudan

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for 50,000 boxe...

Read more

17 Feb 2025 17:51

News

Shelter Pharma to conduct board meeting

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 8 January 2...

Read more

03 Jan 2025 16:38

News

Shelter Pharma to announce Quarterly Result

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 30 October ...

Read more

25 Oct 2024 10:53

News

Board of Shelter Pharma recommends final dividend

Shelter Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

09 Sep 2024 10:57

News

Shelter Pharma schedules AGM

Shelter Pharma announced that the 17th Annual General Meeting (AGM) of the company will be...

Read more

09 Sep 2024 10:57

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Shelter Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Shelter Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Suven Pharmaceuticals Ltd and Shelter Pharma Ltd

Which company has a larger market capitalization, Suven Pharmaceuticals Ltd or Shelter Pharma Ltd?

Market cap of Suven Pharmaceuticals Ltd is 27,815 Cr while Market cap of Shelter Pharma Ltd is 44 Cr

What are the key factors driving the stock performance of Suven Pharmaceuticals Ltd and Shelter Pharma Ltd?

The stock performance of Suven Pharmaceuticals Ltd and Shelter Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Suven Pharmaceuticals Ltd and Shelter Pharma Ltd?

As of May 27, 2025, the Suven Pharmaceuticals Ltd stock price is INR ₹1092.65. On the other hand, Shelter Pharma Ltd stock price is INR ₹38.5.

How do dividend payouts of Suven Pharmaceuticals Ltd and Shelter Pharma Ltd compare?

To compare the dividend payouts of Suven Pharmaceuticals Ltd and Shelter Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions